Remarkably, they suppress the transcriptional activation mediated by the oestrogen and androgen receptors and reduce the cell viability in tumor cell lines, including prostate cancer cells (Tohyama et al., 2012). The gene discussed is AR; the disease is Familial prostate cancer.